| Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) A Fernandez, N Karavitaki, JAH Wass Clinical endocrinology 72 (3), 377-382, 2010 | 1281 | 2010 |
| Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. SMH Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R J Clin Endocrinol Metab., 2016 | 834 | 2016 |
| Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. SMH Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R J Clin Endocrinol Metab, 0 | 834* | |
| Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up N Karavitaki, C Brufani, JT Warner, CBT Adams, P Richards, O Ansorge, ... Clinical endocrinology 62 (4), 397-409, 2005 | 661 | 2005 |
| Craniopharyngiomas N Karavitaki, S Cudlip, CBT Adams, JAH Wass Endocrine reviews 27 (4), 371-397, 2006 | 612 | 2006 |
| Consensus on diagnosis and management of Cushing's disease: a guideline update M Fleseriu, R Auchus, I Bancos, A Ben-Shlomo, J Bertherat, NR Biermasz, ... The lancet Diabetes & endocrinology 9 (12), 847-875, 2021 | 490 | 2021 |
| Epidemiology of acromegaly: review of population studies A Lavrentaki, A Paluzzi, JAH Wass, N Karavitaki Pituitary 20, 4-9, 2017 | 389 | 2017 |
| From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal SL Asa, O Casar-Borota, P Chanson, E Delgrange, P Earls, S Ezzat, ... Endocrine-related cancer 24 (4), C5-C8, 2017 | 313 | 2017 |
| Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement. GA Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS ... Pituitary, 2017 | 261 | 2017 |
| Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary … N Karavitaki, G Thanabalasingham, HCA Shore, R Trifanescu, O Ansorge, ... Clinical endocrinology 65 (4), 524-529, 2006 | 260 | 2006 |
| Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients E Daniel, S Aylwin, O Mustafa, S Ball, A Munir, K Boelaert, V Chortis, ... The Journal of Clinical Endocrinology & Metabolism 100 (11), 4146-4154, 2015 | 217 | 2015 |
| Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study RN Clayton, PW Jones, RC Reulen, PM Stewart, ZK Hassan-Smith, ... The lancet Diabetes & endocrinology 4 (7), 569-576, 2016 | 202 | 2016 |
| What is the natural history of nonoperated nonfunctioning pituitary adenomas? N Karavitaki, K Collison, J Halliday, JV Byrne, P Price, S Cudlip, ... Clinical endocrinology 67 (6), 938-943, 2007 | 192 | 2007 |
| Therapy in endocrine disease: etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review VA Preda, J Sen, N Karavitaki, AB Grossman European Journal of Endocrinology 167 (2), 137-143, 2012 | 191 | 2012 |
| Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers LC Hernández-Ramírez, P Gabrovska, J Dénes, K Stals, G Trivellin, ... The Journal of Clinical Endocrinology & Metabolism 100 (9), E1242-E1254, 2015 | 182 | 2015 |
| The cortisol stress response induced by surgery: A systematic review and meta‐analysis A Prete, Q Yan, K Al‐Tarrah, HK Akturk, LJ Prokop, F Alahdab, MA Foster, ... Clinical endocrinology 89 (5), 554-567, 2018 | 179 | 2018 |
| Rathke’s cleft cysts R Trifanescu, O Ansorge, JAH Wass, AB Grossman, N Karavitaki Clinical endocrinology 76 (2), 151-160, 2012 | 175 | 2012 |
| Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway HS Chahal, G Trivellin, CA Leontiou, N Alband, RC Fowkes, A Tahir, ... The Journal of Clinical Endocrinology & Metabolism 97 (8), E1411-E1420, 2012 | 172 | 2012 |
| Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up G Ntali, A Asimakopoulou, T Siamatras, J Komninos, D Vassiliadi, ... European journal of endocrinology 169 (5), 715-723, 2013 | 171 | 2013 |
| Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement V Chortis, AE Taylor, P Schneider, JW Tomlinson, BA Hughes, DM O'Neil, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 161-171, 2013 | 166 | 2013 |
